Implementation of a Web-based App for Screening in Men in a Malaysian Primary Care Setting (iScreenMen)

The purpose of this study is to determine how to successfully implement ScreenMen in the primary care setting. ScreenMen is a mobile web-based app that has been developed to increase the uptake of screening in men. ScreenMen undertook a vigorous and systematic approach in its development. It was developed based on theories, evidence and needs of men. ScreenMen particularly target men in the age group of 20 to 50 years as this group of men usually do not attend any health screening. This research is necessary because ScreenMen has yet to be implemented in the primary care setting. The study will last about five months and your participation will be about five months.

Study Overview

• Status: Completed
• Conditions: Implementation; Men's Health Screening; Web-based Application
• Intervention / Treatment: Behavioral: Tailored implementation intervention

• Study Type: Interventional
• Enrollment (Actual): 101
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Malaysia
  • Kuala Lumpur, Malaysia, 56100
    • Klinik Kesihatan Cheras Baru

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. Healthcare providers that were involved in the clinic health screening program.
2. Patients who were aged 18 years and above were eligible to participate.

Exclusion Criteria:

1. Temporary healthcare providers (working in the clinic less than six months during the study period) and those who were away on leave.
2. Patients who did not understand Bahasa Malaysia, English or Mandarin, cognitively impaired, had an active psychiatric illness or were too ill.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Screening
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Tailored implementation intervention; The tailored implementation intervention comprised of six implementation strategies: 1) Involve executive boards, 2) Mandate change, 3) Provide education and training, 4) Identify and prepare champions, 5) The use of information and communication technology and 6) Audit and provide feedback.	Behavioral: Tailored implementation intervention; The tailored implementation intervention comprised of six implementation strategies: 1) Involve executive boards, 2) Mandate change, 3) Provide education and training, 4) Identify and prepare champions, 5) The use of information and communication technology and 6) Audit and provide feedback.; Other Names: ScreenMen

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Reach	Number of healthcare providers who attended the workshop / Number of healthcare providers who were invited to the workshop.	Beginning of intervention
Reach	The number of patients who accessed ScreenMen.	Through study completion, 5 months.
Adoption of ScreenMen using qualitative methods	Factors affecting the participation of healthcare providers in adopting ScreenMen in daily practice using qualitative interviews.	5 months into study
Implementation of ScreenMen using qualitative methods	Factors affecting the implementation of ScreenMen daily practice using qualitative interviews.	5 months into study
Maintenance of ScreenMen using qualitative methods	Intention to implement ScreenMen and factors influencing the decision using qualitative methods.	5 months into study

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Impact of COVID-19 on the clinic using qualitative methods	The clinic situation during the COVID-19 pandemic and how it affected daily practice using qualitative methods.	5 months into study

Collaborators and Investigators

• Sponsor: University of Malaya
• Investigators: Principal Investigator: Chirk Jenn Ng, PhD, University of Malaya

Study record dates

Study Major Dates

• Study Start (Actual): January 14, 2021
• Primary Completion (Actual): June 6, 2021
• Study Completion (Actual): June 6, 2021

Study Registration Dates

• First Submitted: April 7, 2024
• First Submitted That Met QC Criteria: April 24, 2024
• First Posted (Actual): April 29, 2024

Study Record Updates

• Last Update Posted (Actual): April 29, 2024
• Last Update Submitted That Met QC Criteria: April 24, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Keywords: mass screening
• Other Study ID Numbers: NMRR-20-2188-56086 IIR

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No